Patent assignee · GB · COMPANY

Redx Pharma PLC

15Patents

15Active

15Granted

48Portfolio score

Filing activity: Jan 27, 2014 → Apr 3, 2023

Most-cited patents

Patent	Title	Area	Cited by	Status
US10183939B2	Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers	Chemistry; Metallurgy	36	Active
US10047079B2	N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway	Chemistry; Metallurgy	6	Active
US10202375B2	N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors	Chemistry; Metallurgy	5	Active
US10793560B2	N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway	Chemistry; Metallurgy	2	Active
US9850234B2	Pyridine derivatives as soft rock inhibitors	Chemistry; Metallurgy	1	Active
US10793562B2	N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors	Chemistry; Metallurgy	1	Active
US11643408B2	N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway	Chemistry; Metallurgy	1	Active
US9579319B2	Heterocyclic compounds as hedgehog signaling pathway inhibitors	Chemistry; Metallurgy	1	Active
US11497751B2	Modulators of Rho-associated protein kinase	Chemistry; Metallurgy	1	Active
US9682963B2	Pyridine derivatives as soft rock inhibitors	Chemistry; Metallurgy	1	Active
US10385065B2	Antibacterial compounds	Emerging Cross-Sectional Technologies	0	Active
US11878020B2	Modulators of Rho-associated protein kinase	Chemistry; Metallurgy	0	Active
US12202826B2	N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway	Chemistry; Metallurgy	0	Active
US10487093B2	Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds	Emerging Cross-Sectional Technologies	0	Active
US11459326B2	N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.